Molybdenum Cofactor Deficiency Type
📧 Sign up to get email alerts when something new happens for Molybdenum Cofactor Deficiency Type.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-10-27FDA Approved: NULIBRY — Supplemental Application (Sentynl Therapeutics, Inc.)
The FDA approved a supplemental application for NULIBRY (fosdenopterin hydrobromide) from Sentynl Therapeutics, Inc.
-
FDA approval · 2021-02-26FDA Approved: NULIBRY — Original Application (Sentynl Therapeutics, Inc.)
FDA approved NULIBRY (fosdenopterin hydrobromide) under an original application from Sentynl Therapeutics for the treatment of molybdenum co…